Clinical and Bacteriological Specificities of Escherichia coli Bloodstream Infections From Biliary Portal of Entries

J Infect Dis. 2024 Jun 14;229(6):1679-1687. doi: 10.1093/infdis/jiad586.

Abstract

Background: Escherichia coli is frequently responsible for bloodstream infections (BSIs). Among digestive BSIs, biliary infections appear to be less severe. Respective roles of host factors, bacterial determinants (phylogroups, virulence, and antibiotic resistance), and portal of entry on outcome are unknown.

Methods: Clinical characteristics and prognosis of 770 episodes of E coli BSI were analyzed and isolates sequenced (Illumina technology) comparing phylogroups, multilocus sequence type, virulence, and resistance gene content. BSI isolates were compared with 362 commensal E coli from healthy subjects.

Results: Among 770 episodes, 135 were biliary, 156 nonbiliary digestive, and 479 urinary. Compared to urinary infections, BSIs of digestive origin occurred significantly more in men, comorbid, and immunocompromised patients. Digestive portal of entry was significantly associated with septic shock and death. Among digestive infections, patients with biliary infections were less likely to die (P = .032), despite comparable initial severity. Biliary E coli resembled commensals (phylogroup distribution, sequence type, and few virulence-associated genes) whereas nonbiliary digestive and urinary strains carried many virulence-associated genes.

Conclusions: Escherichia coli strains responsible for biliary infections exhibit commensal characteristics and are associated with lower mortality rates, despite similar initial severity, than other digestive BSIs. Biliary drainage in addition to antibiotics in the management of biliary infections may explain improved outcome.

Keywords: Escherichia coli; biliary tract infections; bloodstream infections; phylogeny; whole genome sequencing.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia* / microbiology
  • Biliary Tract Diseases / microbiology
  • Drug Resistance, Bacterial / genetics
  • Escherichia coli Infections* / microbiology
  • Escherichia coli* / genetics
  • Escherichia coli* / isolation & purification
  • Escherichia coli* / pathogenicity
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multilocus Sequence Typing
  • Phylogeny
  • Urinary Tract Infections / microbiology
  • Virulence / genetics
  • Virulence Factors / genetics

Substances

  • Virulence Factors
  • Anti-Bacterial Agents